Jäger Elisabeth, Schulz Angela, Lede Vera, Lin Chen-Ching, Schöneberg Torsten, Le Duc Diana
Institute of Biochemistry, University of Leipzig, 04103 Leipzig, Germany; Rheumatology Unit, Department of Internal Medicine, University of Leipzig, 04103 Leipzig, Germany;
Institute of Biochemistry, University of Leipzig, 04103 Leipzig, Germany; Integrated Research and Treatment Center Adiposity Diseases, Medical Faculty, University of Leipzig, 04103 Leipzig, Germany; and.
J Immunol. 2016 Mar 15;196(6):2504-13. doi: 10.4049/jimmunol.1501326. Epub 2016 Feb 5.
Dendritic cells (DCs) are specifically equipped with the G protein-coupled receptor 34 (GPR34). Tight regulation of GPR34 gene expression seems highly important for proper immunological functions, because the absence of this receptor leads to an alteration of the immune response, whereas overexpression was reported to be involved in neuroinflammation. However, the regulatory mechanism of GPR34 expression has not yet been investigated. Whole-transcriptome RNA sequencing analysis from spleens and DCs of GPR34 knockout and wild-type mice, combined with protein-protein interaction data, revealed functional modules affected by the absence of this receptor. Among these, NF-κB, MAPK, and apoptosis-signaling pathways showed high significance. Using murine DCs we experimentally show that NF-κB and MAPK pathways are involved in the downregulation of GPR34. DCs lacking GPR34 have a higher caspase-3/7 activity and increased apoptosis levels. Our study reveals a novel role of GPR34 in the fate of DCs and identifies a regulatory mechanism that could be relevant for treatment of GPR34-overexpressing pathologies, such as neuroinflammatory or cancer conditions.
树突状细胞(DCs)特异性地表达G蛋白偶联受体34(GPR34)。GPR34基因表达的严格调控对于正常免疫功能似乎极为重要,因为该受体缺失会导致免疫反应改变,而据报道其过表达与神经炎症有关。然而,GPR34表达的调控机制尚未得到研究。对GPR34基因敲除小鼠和野生型小鼠的脾脏及DCs进行全转录组RNA测序分析,并结合蛋白质-蛋白质相互作用数据,揭示了受该受体缺失影响的功能模块。其中,NF-κB、MAPK和凋亡信号通路具有高度显著性。利用小鼠DCs,我们通过实验表明NF-κB和MAPK通路参与了GPR34的下调。缺乏GPR34的DCs具有更高的caspase-3/7活性和更高的凋亡水平。我们的研究揭示了GPR34在DCs命运中的新作用,并确定了一种可能与治疗GPR34过表达相关疾病(如神经炎症或癌症)有关的调控机制。